StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3076% above fair value
$58.31−0.97 (-1.64%)

Close on Nov 18, 2026Market cap $2.00BP/E 39.7Yield –

Ingevity operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Ingevity's operating income for the twelve months ending Dec 31, 2024 was $425.90M, up 0.6% year over year. For fiscal 2025 it was $418.70M, down 1.7% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $452.60M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$418.70M-1.7%
FY2024Dec 31, 2024$425.90M+0.6%
FY2023Dec 31, 2023$423.20M-6.5%
FY2022Dec 31, 2022$452.60M+7.2%
FY2021Dec 31, 2021$422.20M+6.1%
FY2020Dec 31, 2020$397.90M+0.3%
FY2019Dec 31, 2019$396.90M+23.8%
FY2018Dec 31, 2018$320.50M+32.1%
FY2017Dec 31, 2017$242.70M+48.3%
FY2016Dec 31, 2016$163.60M-1.6%
FY2015Dec 31, 2015$166.30M-22.0%
FY2014Dec 31, 2014$213.30M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$137.50M+55.9%
Q3 FY2024Sep 30, 2024$110.20M-0.2%
Q2 FY2024Jun 30, 2024$101.30M-16.1%
Q1 FY2024Mar 31, 2024$76.90M-26.0%
Q4 FY2023Dec 31, 2023$88.20M+18.7%
Q3 FY2023Sep 30, 2023$110.40M-20.1%
Q2 FY2023Jun 30, 2023$120.70M-0.3%
Q1 FY2023Mar 31, 2023$103.90M-12.7%
Q4 FY2022Dec 31, 2022$74.30M-6.7%
Q3 FY2022Sep 30, 2022$138.20M+15.6%
Q2 FY2022Jun 30, 2022$121.10M+2.9%
Q1 FY2022Mar 31, 2022$119.00M+12.9%
Q4 FY2021Dec 31, 2021$79.60M-28.2%
Q3 FY2021Sep 30, 2021$119.50M-6.3%
Q2 FY2021Jun 30, 2021$117.70M+75.1%
Q1 FY2021Mar 31, 2021$105.40M+14.3%
Q4 FY2020Dec 31, 2020$110.90M+21.7%
Q3 FY2020Sep 30, 2020$127.60M+11.9%
Q2 FY2020Jun 30, 2020$67.20M-38.0%
Q1 FY2020Mar 31, 2020$92.20M+10.4%
Q4 FY2019Dec 31, 2019$91.10M+24.3%
Q3 FY2019Sep 30, 2019$114.00M+25.7%
Q2 FY2019Jun 30, 2019$108.30M+21.1%
Q1 FY2019Mar 31, 2019$83.50M+24.4%
Q4 FY2018Dec 31, 2018$73.30M-11.7%
Q3 FY2018Sep 30, 2018$90.70M+44.7%
Q2 FY2018Jun 30, 2018$89.40M+56.6%
Q1 FY2018Mar 31, 2018$67.10M+68.2%
Q4 FY2017Dec 31, 2017$83.00M+224.2%
Q3 FY2017Sep 30, 2017$62.70M+26.7%
Q2 FY2017Jun 30, 2017$57.10M–
Q1 FY2017Mar 31, 2017$39.90M–
Q4 FY2016Dec 31, 2016$25.60M–
Q3 FY2016Sep 30, 2016$49.50M–

More Ingevity figures

See a number that looks wrong?